PIII News and Press, P3 Health Partners Inc. From 08/14/25

2025-08-14 22:21:20 ET More on P3 Health Partners P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on P3 Health Partners Historical earnings data for P3 Health Partners Financial information for P3 Health Par...

2025-08-14 16:26:35 ET More on P3 Health Partners Seeking Alpha’s Quant Rating on P3 Health Partners Historical earnings data for P3 Health Partners Financial information for P3 Health Partners Read the full article on Seeking Alpha For further...

Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast ...

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...

P3 Health Partners Inc. (PIII) is expected to report $-3.29 for Q2 2025

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14...

2025-05-15 22:38:40 ET More on P3 Health Partners P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript P3 Health Partners targets profitability in 2025 with adjusted EBITDA guidance...

2025-05-15 22:37:50 ET P3 Health Partners Inc. (PIII) Q1 2025 Earnings Conference Call May 15, 2025, 04:30 PM ET Company Participants Ryan Halstead - Managing Director, Gilmartin Group LLC, IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medica...

2025-05-15 16:25:38 ET More on P3 Health Partners P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript P3 Health Partners targets profitability in 2025 with adjusted EBITDA guidance of up to $5M P3 Health Partners GAAP EPS of -$0.36 misses by $0...

Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announ...